The important announcements for Hong Kong stocks today are as follows:

1) Company News

$TENCENT (00700.HK)$ A sale of 0.113 billion US dollars will be made to $CHINA RUYI (00136.HK)$ Selling 30% of the equity of the Game Publisher Yonghang Technology.

CHINA RUYI announced on Monday evening on HKEX that it agreed to sell a 30% stake in Beijing Yonghang Technology Co., Ltd. to TENCENT for a total consideration of 0.825 billion RMB (0.113 billion USD). This includes 0.7425 billion RMB in Cash and the issuance of approximately 36.7 million consideration shares to TENCENT or its designated party at a price of 2.432 HKD per share. The core Assets of the target company include games such as 'QQ Dance', 'QQ Dance 2', and 'QQ Dance Mobile'.

$CHINA LONGYUAN (00916.HK)$By 2024, a total of 75.5462 million megawatt-hours of electricity generation was completed, a year-on-year decrease of 0.89%, mainly due to the reduction in installed capacity of thermal power holdings. During the period, the electricity generation from photovoltaics and other renewable energy sources grew by 72.04%, while electricity generation from thermal power decreased by 30.59%.

$GANGLONG CHINA (06968.HK)$In 2024, the contract sales amount achieved was approximately 5.4093 billion yuan.

$KWG GROUP (01813.HK)$In December 2024, the contract sales amount was 0.97 billion yuan, a year-on-year decrease of 26.5%.

$BOJUN EDU (01758.HK)$Subscription completed.$YIBIN BANK (02596.HK)$20.463 million shares are being issued internationally.

$GANFENGLITHIUM (01772.HK)$The GANFENGLITHIUM contributed 0.5 billion yuan to the NAM CHEONG GANFENGLITHIUM and acquired an 83.33% equity stake.

$3SBIO (01530.HK)$SHENYANG 3SBIO will obtain the commercialization rights for multiple indications of the HER2ADC drug DB-1303 developed by YINGEN BIO.

$LAEKNA-B (02105.HK)$The Phase I single ascending dose study (SAD study) of LAE102 for the treatment of obesity has been successfully completed.

$IMMUNEONCO-B (01541.HK)$: The IB/II phase clinical trial for the first-line treatment of NSCLC with IMM2510 combined chemotherapy has completed its first patient dosing.

$CG SERVICES (06098.HK)$ : The non-wholly owned subsidiary CG SERVICES has accrued an impairment provision of approximately RMB 0.8 billion to RMB 1.1 billion (goodwill and other intangible asset impairment).

$361 DEGREES (01361.HK)$: The retail revenue (calculated at retail value) of 361's main brand products is expected to achieve a positive growth of approximately 10% compared to the same period in 2023 in the fourth quarter of 2024.

2) Increase and decrease in holdings, and repurchase dynamics

$WUXI APPTEC (02359.HK)$: Recently accumulated sales.$WUXI XDC (02268.HK)$86 million shares, cashing out approximately 2.426 billion Hong Kong dollars.

WUXI APPTEC announced that on November 8, 2024, and January 10, 2025, through two block trades, the company sold a total of 86 million shares of WUXI XDC, accounting for approximately 7.17% of the issued share capital. The cash proceeds from this sale will be used to accelerate the advancement of global capacity and capability construction, attract and retain outstanding talent, and continuously strengthen the company's unique integrated CRDMO business model.

In addition, the investment income realized from the sale of WUXI XDC shares over the past twelve months amounted to RMB 2.016 billion, accounting for more than 10% of the net income for the 2023 fiscal year.

$TENCENT (00700.HK)$Spent 1.503 billion Hong Kong dollars to repurchase 4.08 million shares, with a repurchase price of 364.8-371.2 Hong Kong dollars.

$AIA (01299.HK)$Spent 0.337 billion Hong Kong dollars to repurchase 6.505 million shares, with a repurchase price of 50.95-52.3 Hong Kong dollars.

$XIAOMI-W (01810.HK)$Spent 73.925 million HKD to repurchase 2.25 million shares at a repurchase price of 32.8-32.9 HKD.

$COSCO SHIP HOLD (01919.HK)$Spent 62.4041 million HKD to repurchase 5.3 million shares at a repurchase price of 11.68-11.88 HKD.

$ZOOMLION (01157.HK)$Spent 17.131 million HKD to repurchase 3.2176 million shares at a repurchase price of 5.22-5.39 HKD.

$TIMES ELECTRIC (03898.HK)$Spent 17.9199 million HKD to repurchase 0.6116 million shares at a repurchase price of 29.05-29.55 HKD.

$AAC TECH (02018.HK)$: Acquired 14.4285 million HKD to repurchase 0.408 million shares, with a repurchase price of 34.55-35.75 HKD per share.

$WELLCELL HOLD (02477.HK)$: The controlling shareholder, Jingwei Tiandi Group, completed the sale of 99.5 million company shares.

Editor/Rocky